Antonio Rosi Selected Research

Antonio Rosi Research Topics

11	Neoplasms (Cancer) 03/2019 - 10/2005
2	Carcinoma (Carcinomatosis) 01/2019 - 04/2006
1	COVID-19 01/2022
1	Infections 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Tongue Neoplasms (Tongue Neoplasm) 09/2015
1	Paralysis (Palsy) 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2014
1	Breast Neoplasms (Breast Cancer) 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2006

5	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2009
4	Biotin (Vitamin H)FDA Link 03/2019 - 01/2009
3	Cetuximab (Erbitux)FDA Link 03/2019 - 10/2014
3	TenascinIBA 01/2019 - 10/2005
3	Monoclonal AntibodiesIBA 01/2019 - 04/2006
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 04/2017
2	AntibodiesIBA 04/2017 - 10/2005
1	Immunoglobulin FragmentsIBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 03/2019
1	Histones (Histone)IBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	TubulinIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	EnzymesIBA 01/2019
1	pertuzumabIBA 04/2017
1	ErbB Receptors (EGF Receptor)IBA 04/2017
1	Panitumumab (Vectibix)FDA Link 04/2017
1	AerosolsIBA 10/2014
1	AvidinIBA 10/2010
1	AntidotesIBA 10/2010
1	OxavidinIBA 01/2009
1	Artificial ReceptorsIBA 01/2009
1	ST2146biotIBA 04/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2005